Mangoceuticals, Inc. (MGRX)

Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $17.51 million. The enterprise value is $18.04 million.

Market Cap	17.51M
Enterprise Value	18.04M

Important Dates

The last earnings date was Thursday, August 14, 2025, after market close.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Mangoceuticals has 10.54 million shares outstanding. The number of shares has increased by 240.49% in one year.

Current Share Class	10.54M
Shares Outstanding	10.54M
Shares Change (YoY)	+240.49%
Shares Change (QoQ)	+117.36%
Owned by Insiders (%)	19.76%
Owned by Institutions (%)	2.77%
Float	7.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.46
Forward PS	n/a
PB Ratio	0.92
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	34.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.07, with a Debt / Equity ratio of 0.03.

Current Ratio	0.07
Quick Ratio	0.06
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -85.90% and return on invested capital (ROIC) is -45.91%.

Return on Equity (ROE)	-85.90%
Return on Assets (ROA)	-43.25%
Return on Invested Capital (ROIC)	-45.91%
Return on Capital Employed (ROCE)	-64.88%
Revenue Per Employee	$172,010
Profits Per Employee	-$5.03M
Employee Count	3
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.25% in the last 52 weeks. The beta is 2.42, so Mangoceuticals's price volatility has been higher than the market average.

Beta (5Y)	2.42
52-Week Price Change	-59.25%
50-Day Moving Average	1.69
200-Day Moving Average	2.46
Relative Strength Index (RSI)	50.54
Average Volume (20 Days)	90,297

Short Selling Information

The latest short interest is 279,205, so 2.65% of the outstanding shares have been sold short.

Short Interest	279,205
Short Previous Month	202,063
Short % of Shares Out	2.65%
Short % of Float	3.73%
Short Ratio (days to cover)	1.83

Income Statement

In the last 12 months, Mangoceuticals had revenue of $516,030 and -$15.08 million in losses. Loss per share was -$3.14.

Revenue	516,030
Gross Profit	314,786
Operating Income	-12.48M
Pretax Income	-9.02M
Net Income	-15.08M
EBITDA	-10.54M
EBIT	-12.48M
Loss Per Share	-$3.14

Balance Sheet

The company has $101,019 in cash and $630,117 in debt, giving a net cash position of -$529,098 or -$0.05 per share.

Cash & Cash Equivalents	101,019
Total Debt	630,117
Net Cash	-529,098
Net Cash Per Share	-$0.05
Equity (Book Value)	19.24M
Book Value Per Share	1.81
Working Capital	-1.48M

Cash Flow

Operating Cash Flow	-5.83M
Capital Expenditures	n/a
Free Cash Flow	-5.83M
FCF Per Share	-$0.55

Margins

Gross Margin	61.00%
Operating Margin	-2,419.08%
Pretax Margin	-2,752.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-240.49%
Shareholder Yield	-240.49%
Earnings Yield	-86.09%
FCF Yield	-33.28%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Oct 16, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Mangoceuticals has an Altman Z-Score of 0.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.34
Piotroski F-Score	2